AMMONIA, FATIGUE AND VENTILATION DURING EXERCISE
AMMONIA, FATIGUE AND VENTILATION DURING EXERCISE
批准号:
6280054
负责人:
DAVID M SYSTROM
金额:
$2.74万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30
中文摘要
在考虑减少(糖原)的大强度运动时
消耗或消除(麦卡德尔综合征,MCAS)骨骼肌
产生乳酸,注意疲劳和呼吸控制
完好无损。GD和MCAS的特点是NH3在
肌肉和血液。NH3抑制氧化代谢,是一种已知的
呼吸性昏迷药在肝病患者休息期的应用。它是
因此,NH3可能导致疲劳和呼吸困难。
运动时应注意不发生极地酸血症。另一种可能性是,
运动骨骼肌代谢产物直接刺激换气
通过神经通路。这种所谓的“新陈代谢反射”可以被研究
通过非侵入性31P磁共振波谱测量
双侧静脉闭塞(BVO)时的骨骼肌锻炼
血压手铐。
一种孤儿药物(苯丁酸钠,NaPB)最近被
FDA用于预防和治疗与以下疾病相关的高氨血症
儿童和成人的尿素循环障碍。峰值血浆水平是
口服5g后1h达峰。NaPB通过β氧化转化
线粒体中的苯乙酸钠盐(Napa)。纳帕与
肝脏和肾脏中的谷氨酰胺形成苯乙酰谷氨酰胺,
与它的两个废氮一起,在随后的尿液中排出
24小时。100多年的用药经验表明,
严重的毒性。因此,我们希望使用单剂量的NaPB
抑制肌肉和血液中的NH3,并确定其在疲劳和
运动时的通风。
英文摘要
During heavy exercise under considerations which decrease (glycogen
depletion, GD) or eliminate (McArdle's Syndrome, McAS) skeletal muscle
lactic acid production, fatigue is noted and ventilatory control is
intact. GD and McAS are characterized by an exorbitant NH3 rise in
muscle and blood. NH3 inhibits oxidative metabolism3 and is a known
respiratory analeptic in resting patients with liver disease. It is
therefore possible that NH3 contributes to fatigue and dyspenea during
exercise when lctic acidemia does not. Another possibility is that
exercising skeletal muscle metabolites stimulate ventilation directly
through a neural pathway. This so-called "metaboreflex" can be examined
by non-invasive 31P magnetic resonance spectroscopy measurements of
exercising skeletal muscle during bilateral venous occlusion (BVO) by
blood pressure cuffs.
An orphan drug (sodium phenylbutyrate, NaPB) was recently approved by
the FDA for prevention and treatment of hyperammonemia associated with
urea cycle disorders of children and adults. Peak plasma levels are
acheived 1 h after 5 g po by mouth. NaPB is converted by betaoxidation
in the mitochondrion to Na Phenylacetate (NaPA). NaPA congugates with
glutamine in the liver and kidney to form phenylacetylglutamine which,
with its 2 waste nitrogens, is excreted in the urine over the ensuing
24 h. Over 100 patient-years experience with the drug have revealed no
serious toxicity. We therefore wish to use a single oral dose of NaPB
to suppress muscle and blood NH3 and determine its role in fatigue and
ventilation during exercise.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SKELETAL MUSCLE DYSFUNCTION IN COPD
-
批准号:6033661
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2000
-
负责人:DAVID M SYSTROM
-
依托单位:
SKELETAL MUSCLE DYSFUNCTION IN COPD
-
批准号:6708375
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2000
-
负责人:DAVID M SYSTROM
-
依托单位:
SKELETAL MUSCLE DYSFUNCTION IN COPD
-
批准号:6625217
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2000
-
负责人:DAVID M SYSTROM
-
依托单位:
SKELETAL MUSCLE DYSFUNCTION IN COPD
-
批准号:6329991
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2000
-
负责人:DAVID M SYSTROM
-
依托单位:
SKELETAL MUSCLE DYSFUNCTION IN COPD
-
批准号:6476711
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2000
-
负责人:DAVID M SYSTROM
-
依托单位:
ANAEROBIC THRESHOLD DURING EXERCISE
-
批准号:3083022
-
项目类别:
-
资助金额:$7.74万
-
财政年份:1991
-
负责人:DAVID M SYSTROM
-
依托单位:
ANAEROBIC THRESHOLD DURING EXERCISE
-
批准号:2210235
-
项目类别:
-
资助金额:$7.52万
-
财政年份:1991
-
负责人:DAVID M SYSTROM
-
依托单位:
ANAEROBIC THRESHOLD DURING EXERCISE
-
批准号:3083021
-
项目类别:
-
资助金额:$7.74万
-
财政年份:1991
-
负责人:DAVID M SYSTROM
-
依托单位:
AMMONIA, FATIGUE AND VENTILATION DURING EXERCISE
-
批准号:6119033
-
项目类别:
-
资助金额:$3.2万
-
财政年份:--
-
负责人:DAVID M SYSTROM
-
依托单位:
国内基金
海外基金
SIRT5/ammonia信号通路介导适应性自噬在急性心肌梗死中的作用及其机制研究
-
批准号:81900312
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:汪芸玏
-
依托单位: